Table I.
Cell line | KRAS or BRAF mutation | 3D growth pattern | Anoikis resistance | (Refs.) |
---|---|---|---|---|
Caco-2 | None | Polarized cyst | NS | (32,52) |
Caco-2 | None | Polarized cyst | + | Patankar M (Present study) |
Caco2-KRAS | KRAS, G12V | Solid | NS | (32) |
HCT 116 | KRAS, G13D | Solid | NS | (15,53–55) |
NS | + | |||
SW 408 | KRAS, G12V | Solid | NS | (52,54) |
Caco2-KRAS | KRAS, G12V | Solid | + | Patankar M (present study) |
Caco2-BRAF | BRAF, V600E | Solid | NS | (32) |
HT29 | BRAF, V600E | Solid | NS | (15,53,54) |
NS | + | |||
DLD-1 | BRAF, V600E | Solid | NS | (53,54) |
Caco2-BRAF | BRAF, V600E | Solid | + | Patankar M (present study) |
3-D, 3 dimensional; NS, not studied; +, studied.